Skip to main content

Advertisement

Open Peer Review Reports for: Targeting of CD34 + CD38 - cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
24 Apr 2012 Submitted Original manuscript
15 Jun 2012 Reviewed Reviewer Report - Judith Karp
30 Jun 2012 Reviewed Reviewer Report - Jörg Cammenga
25 Jul 2012 Author responded Author comments - claire SEEDHOUSE
Resubmission - Version 2
25 Jul 2012 Submitted Manuscript version 2
9 Sep 2012 Reviewed Reviewer Report - Judith Karp
19 Sep 2012 Reviewed Reviewer Report - Jörg Cammenga
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
21 Sep 2012 Editorially accepted
26 Sep 2012 Article published 10.1186/1471-2407-12-431

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement